» Articles » PMID: 26616161

Zeolite Nanoparticles for Selective Sorption of Plasma Proteins

Overview
Journal Sci Rep
Specialty Science
Date 2015 Dec 1
PMID 26616161
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The affinity of zeolite nanoparticles (diameter of 8-12 nm) possessing high surface area and high pore volume towards human plasma proteins has been investigated. The protein composition (corona) of zeolite nanoparticles has been shown to be more dependent on the plasma protein concentrations and the type of zeolites than zeolite nanoparticles concentration. The number of proteins present in the corona of zeolite nanoparticles at 100% plasma (in vivo state) is less than with 10% plasma exposure. This could be due to a competition between the proteins to occupy the corona of the zeolite nanoparticles. Moreover, a high selective adsorption for apolipoprotein C-III (APOC-III) and fibrinogen on the zeolite nanoparticles at high plasma concentration (100%) was observed. While the zeolite nanoparticles exposed to low plasma concentration (10%) exhibited a high selective adsorption for immunoglobulin gamma (i.e. IGHG1, IGHG2 and IGHG4) proteins. The zeolite nanoparticles can potentially be used for selectively capture of APOC-III in order to reduce the activation of lipoprotein lipase inhibition during hypertriglyceridemia treatment. The zeolite nanoparticles can be adapted to hemophilic patients (hemophilia A (F-VIII deficient) and hemophilia B (F-IX deficient)) with a risk of bleeding, and thus might be potentially used in combination with the existing therapy.

Citing Articles

LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study.

Liang H, Wang R, Cheng R, Ye Z, Zhao N, Zhao X Clin Transl Med. 2025; 15(1):e70160.

PMID: 39783847 PMC: 11714244. DOI: 10.1002/ctm2.70160.


Small molecule modulation of protein corona for deep plasma proteome profiling.

Ashkarran A, Gharibi H, Sadeghi S, Modaresi S, Wang Q, Lin T Nat Commun. 2024; 15(1):9638.

PMID: 39511193 PMC: 11544298. DOI: 10.1038/s41467-024-53966-z.


Deep Plasma Proteome Profiling by Modulating Single Nanoparticle Protein Corona with Small Molecules.

Ashkarran A, Gharibi H, Sadeghi S, Modaresi S, Wang Q, Lin T bioRxiv. 2024; .

PMID: 38496642 PMC: 10942461. DOI: 10.1101/2024.03.06.582595.


Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy.

Mena-Silva D, Alfaro A, Leon A, Guajardo-Correa E, Elgueta E, Diaz P Int J Mol Sci. 2023; 24(13).

PMID: 37446151 PMC: 10342143. DOI: 10.3390/ijms241310967.


Comprehensive and deep profiling of the plasma proteome with protein corona on zeolite NaY.

Ma C, Li Y, Li J, Song L, Chen L, Zhao N J Pharm Anal. 2023; 13(5):503-513.

PMID: 37305782 PMC: 10257194. DOI: 10.1016/j.jpha.2023.04.002.


References
1.
Zhang J, Xin L, Shan B, Chen W, Xie M, Yuen D . PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics. 2011; 11(4):M111.010587. PMC: 3322562. DOI: 10.1074/mcp.M111.010587. View

2.
Zhang Y, Xu C, He Y, Wang X, Xing F, Qiu H . Zeolite/polymer composite hollow microspheres containing antibiotics and the in vitro drug release. J Biomater Sci Polym Ed. 2010; 22(4-6):809-22. DOI: 10.1163/092050610X496242. View

3.
Ji J, Zhang Y, Zhou X, Kong J, Tang Y, Liu B . Enhanced protein digestion through the confinement of nanozeolite-assembled microchip reactors. Anal Chem. 2008; 80(7):2457-63. DOI: 10.1021/ac702218v. View

4.
Rezaee F, Casetta B, Levels J, Speijer D, Meijers J . Proteomic analysis of high-density lipoprotein. Proteomics. 2006; 6(2):721-30. DOI: 10.1002/pmic.200500191. View

5.
Perez-Ramirez J . Zeolite nanosystems: Imagination has no limits. Nat Chem. 2012; 4(4):250-1. DOI: 10.1038/nchem.1310. View